Remove 2024 Remove Bipolar disorder Remove Sleep and mental health
article thumbnail

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

Developed with input from international mental health professionals, the BPD-I™ is freely available for clinical use, education, and research. SHOW MORE Discover the innovative Borderline Personality Disorder Inventory (BPD-I™), a psychodynamically-informed tool for assessing BPD symptoms effectively.

article thumbnail

What Is a Sleep Disorder? A Harmful Dysfunction Analysis

Psychiatric Times

A Harmful Dysfunction Analysis Author(s): Jean-Arthur Micoulaud-Franchi, MD, PhD , Christophe Gauld, MD, PhD +2 More Key Takeaways Sleep medicine lacks a structured definition for disorders, complicating diagnosis and classification compared to psychiatry's DSM framework. SHOW MORE What is a sleep disorder?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Presenting Our August Theme: ADHD

Psychiatric Times

Example topics include ADHD's link with bipolar disorder, anxiety, depression, and cardiovascular risks from long-term medication. Do you have practice tips to offer your fellow mental health clinicians? children, highlighting its significant prevalence and rising diagnosis rates.

article thumbnail

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

Psychiatric Times

An sNDA for Caplyta as an adjunctive treatment for adults with major depressive disorder (MDD) is also currently under FDA review, submitted back in December 2024. sNDA submitted: lumateperone as adjunctive therapy for major depressive disorder. December 3, 2024. points (effect size 0.61) in study 501 and 4.5

article thumbnail

PTSD Is Treatable, But There's No Holy Grail: Insights From Arash Javanbakht, MD

Psychiatric Times

August 9, 2024. September 11, 2024. Suicide risk in people with post-traumatic stress disorder: a cohort study of 3.1 but in what areas can we improve treatment outcomes and real-world functioning for patients with PTSD? but in what areas can we improve treatment outcomes and real-world functioning for patients with PTSD?

article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.

article thumbnail

99 Pubs and Zero Followers? Psychiatric Leadership in the Age of Influencers

Psychiatric Times

Psychiatric Leadership in the Age of Influencers Author(s): Raina Aggarwal, MD Social media shapes mental health discourse, but misinformation and self-diagnosis risks arise as non-professionals dominate the conversation. Lay people are increasingly using terms like these to describe themselves, people they know, and public figures.